Consistent with our finding of the causal role of ANRIL in atherosclerosis, genetic variants of TMEM106B significantly increased the risk of CAD and interacted with ANRIL variants to confer an epistatic effect on risk of CAD (31). This evidence concerns the gene CDKN2B-AS1 and atherosclerosis.